The sodium-hydrogen exchanger (NHE) is integral to the processes that facilitate cell growth and may contribute to the development of left ventricular hypertrophy. The aim of this study was to examine the relationship between platelet sodium-hydrogen exchanger activity and left ventricular mass index (LVMI). Methods: Twenty male untreated Caucasians (mean age ؎ s.d.: 48 ؎ 13; body mass index: 29 ؎ 4 kg/m 2 ) with a wide range of blood pressures were studied (mean BP: 152 ؎ 22/93 ؎ 15 mm Hg; range: 115-190/61-117 mm Hg). Sodium-hydrogen exchanger activity was determined as the rate of sodium-dependent recovery of intracellular pH in isolated platelets loaded with BCECF and acidified to pH 6.25 using nigericin. LVMI was calculated from measurements made by M-mode echocardiography. Associations between continuous variables were examined using parametric tests. Results: The mean rate of pHi recovery was
Introduction
Left ventricular hypertrophy (LVH) is a well-documented complication and a prevalent finding in patients with hypertension. 1 It is a powerful independent predictor of cardiovascular outcome 2 and is a significant risk factor for ischaemia, 3 arrhythmia, 4 left ventricular dysfunction 5 and sudden cardiac death. 6 However, identifying patients susceptible to developing LVH is difficult. The correlation between levels of blood pressure and the magnitude of LVH is poor. [7] [8] [9] Whilst it is clear that the haemodynamic effects of volume overload and increased afterload pressures are central to the development of LVH, non-haemodynamic factors may also be important. 10, 11 Hence, improved understanding of the mechanisms underlying the development of LVH has potentially significant clinical implications.
The sodium-hydrogen exchanger (NHE) is a major regulator of intracellular pH (pHi) and is integral to 2 (range: 56-178) and was not significantly correlated with either systolic (r = 0.39, P = 0.09) or diastolic blood pressure (r ‫؍‬ 0.27, P ‫؍‬ 0.3). Platelet NHE activity was not significantly correlated with LVMI (r ‫؍‬ 0.06; P ‫؍‬ 0.8). Platelet NHE activity was not significantly different between subjects with (n ‫؍‬ 7 with LVMI Ͼ131 g/m 2 ) and without left ventricular hypertrophy (n ‫؍‬ 13).
Conclusions:
The results of this study show that platelet NHE activity is not significantly correlated with LVMI. These data contrast with previously described correlations of LVMI with exchanger activity measured in leucocytes and erythrocytes; and indicate that the relationship between LVMI and exchanger activity may be specific to the cell type in which exchanger activity is measured.
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the processes that facilitate cell growth and hypertrophy. 12, 13 Consequently, enhanced activity of the exchanger may contribute to cell growth and hypertrophy in cardiomyocytes. Interestingly, activity of the exchanger has been reported to be increased in isolated cells from some individuals with essential hypertension.
14 In addition, activity of the NHE in both lymphocytes 15 and erythrocytes 16 has been positively correlated with left ventricular mass index (LVMI) in patients with essential hypertension. Indeed, enalapril-induced regression of LVH in spontaneous hypertensive rats has been shown to be associated with normalisation of sodium-hydrogen exchanger activity. 17 Thus, it is possible that increased activity of the exchanger may be significant in mediating cardiac hypertrophy in such individuals; moreover, it is possible that NHE activity may be used as an intermediate phenotypic marker for the development of LVH.
Therefore, the aim of this study was to investigate this further by examining the relationship between platelet NHE and LVMI in a group of subjects with a wide range of blood pressure.
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Subjects and methods
Subjects
Twenty male Caucasian subjects with a wide range of blood pressures were studied. Subjects were individuals seen by the Blood Pressure Unit at St George's Hospital and were from within the catchment area of the hospital. All subjects had not taken any medication for at least 4 weeks prior to study, had undergone a period of familiarisation with blood pressure measurements, were on their usual sodium diet and were instructed to make urinary collections for 24 h prior to the day of study.
All individuals were studied whilst fasted and in the morning on the day of study. Measurements of blood pressure, weight and height were recorded in each subject. Sitting blood pressures in the subjects were measured after 5 min of rest using an automated oscillometric sphygmomanometer (Omron HEM-705CP), taking the mean of three readings with the appropriate cuff size according to recommendations of the British Hypertension Society. 18 Venous blood was taken for the assessment of NHE activity as described below and further samples simultaneously taken for routine blood biochemical and haematological tests. An echocardiogram was also performed in each subject.
The study was approved by the hospital ethics committee and all patients gave informed consent.
Assessment of platelet sodium-hydrogen activity
Sodium-hydrogen exchanger activity was measured in freshly isolated platelets by a spectrofluorimetric technique using the fluorescence pH dye BCECF-AM [2Ј,7Ј-bis-(2-carboxyethyl)-5-(and -6)-carboxy-fluorescein, acetylmethoxyl ester], as previously described. 19 Measurements of fluorescence in platelets from respective individuals were made in acidloaded platelets and during subsequent sodiumdependent pHi recovery on mixing with sodiumcontaining buffer. Briefly, platelets isolated from venous blood were loaded with BCECF-AM and acidified to an intracellular pH of 6.25 by incubation with nigericin ionophore and acid-loading buffer. For pH recovery, the acid-loaded platelets were then washed with sodium-free buffer containing bovine serum albumin and resuspended in sodium-containing HEPES buffer with pH of 7.4. Fluorescence measurements were recorded for 50 s at 0.5-s intervals in a Perkin-Elmer LS-50B spectrometer (Perkin Elmer, Buckinghamshire, UK), at 37°C with wavelength settings at 440, 495 nm for excitation and 530 nm for emission, using 5 nm and 10 nm slits for excitation and emission respectively. Fluorescence measurements were converted to pH values from calibration curves constructed for each experiment. The subsequent pHi-time data obtained over the first 25 s after initial point of pHi recovery fitted to the following three parameter non-linear equation:
where pHi t ϭ actual pHi at time t; pHi 0 ϭ initial pHi at the start of pHi recovery; pHi f ϭ final achieved pHi; and k ϭ rate constant of pHi recovery. Mean NHE activity was then estimated as the derivative at the initial pH from v ϭ k{pHi f − pHi 0 }.
Echocardiography
Echocardiograms were performed with a Hewlett Packard echogram (Sono 100CC). Standard M-mode echocardiograms were performed with the subject in the partial left decubitus position using a 3.5 MHz transducer or a 2.5 MHz transducer when deeper penetration was required for better views. The characteristic echocardiogram of the mitral valve was identified from the short axis view with the transducer in the third to fifth intercostal spaces. The transducer beam was then angled with the beam perpendicularly through the left ventricle to locate the mitral valve ring and papillary muscles. Measurements of the septum, ventricular cavity and posterior wall were made in both systole and diastole, at or just above the tips of the mitral valve only on recordings showing clear continuous endocardial structures throughout the cardiac cycle.
All subjects had good quality tracings on which the right and left sides of the interventricular septum, endocardial and epicardial surfaces of the posterior wall were recorded continuously throughout the cardiac cycle. The M-mode measurements were taken according to the recommendations of the American Society of Echocardiography (ASE) 21 using a leading-edge to leading-edge convention.
Estimation of left ventricular mass was calculated from end-diastolic measurements of the left ventricular internal diameter (LVID), interventriclar septum (IVS), and posterior wall thickness (PWT) by the following equation 
Statistics and data
Clinical characteristics, parameters of NHE activity and measures of left ventricular mass and mass index are expressed as mean Ϯ standard deviation (s.d.). Two-group comparisons were carried out using unpaired Student's t-test. Using KolmogoroffSmirnoff tests, parameters of NHE activity and measures of left ventricular mass were confirmed to be normally distributed. Subsequent associations between variables were examined using parametric tests and a two-tailed P-value of Ͻ0.05 taken as statistically significant. All statistical tests were carried out using SPSS (SPSS version 8.0 for windows, SPSS Incorporated).
Results
Clinical characteristics of the subjects are detailed in Table 1 Measurements of platelet NHE activity, left ventricular mass and LVMI were successfully made in all subjects. The mean level of intracellular pH achieved from acidification was 6.26 Ϯ 0.12 (range: 6.10-6.45) and the mean rate of pHi recovery was 0.15 Ϯ 0.03 dpHi/s (range: 0.09-0.21). The mean left ventricular mass was 245 Ϯ 70 g (range: 127-367) and LVMI was 120 Ϯ 32 g/m 2 (range: 56-178). LVMI in the study group was not significantly correlated with either systolic (r ϭ 0.39, P ϭ 0.09) or diastolic blood pressure (r ϭ 0.27, P ϭ 0.3).
Platelet NHE activity was not significantly correlated with either left ventricular mass (r ϭ 0.13; P ϭ 0.6) or LVMI (r ϭ 0.06; P ϭ 0.8) in the entire group (Figure 1 ). There was similarly no significant correlation between exchanger activity and LVMI in both the hypertensive (r ϭ 0.1, P ϭ 0.7; n ϭ 13 with blood pressure Ͼ140/90 mm Hg) and normotensive (r ϭ 0.6, P ϭ 0.1; n ϭ 7 with blood pressure Ͻ140/90 mm Hg) subgroups, when individuals were respectively grouped according to their blood pressure. Seven individuals were noted to have left ventricular hypertrophy (LVMI Ͼ131 g/m 2 ). Platelet NHE activity in individuals with LVH was 0.15 Ϯ 0.02 dpHi/s and not significantly different from those without LVH (0.15 Ϯ 0.03 dpHi/s; P ϭ 0.9, n ϭ 13).
Discussion
The aim of this study was to examine the relationship between platelet NHE activity and indices of left ventricular mass. The study included seven subjects with LVH and recruited individuals with a wide range of NHE activity (0.09-0.21 dpHi/s), left ventricular mass (127-367 g) and LVMI (56-178 g/m 2 ). Despite this, the results of the present study showed no direct relationship between maximal platelet NHE activity and measures of left ventricular mass, not only in the entire study group but also in the two respective subgroups of hypertensive and normotensive subjects. Furthermore, the rate of pHi recovery in platelets from subjects with LVH was not significantly different from those without LVH. Consequently, the present study fails to support the hypothesis that rates of maximal NHE activity measured in platelets may predict left ventricular mass in individuals or that exchanger activity contributes significantly to the development of cardiac hypertrophy.
These findings contrast with those from previous studies in which leucocyte 15 and erythrocyte 16 NHE activity were both found to be positively correlated with LVMI in patients with essential hypertension. There may be several possible explanations for this. First, in contrast to previous investigations that showed a positive correlation between LVMI and NHE activity, the present study examined not only hypertensive but also normotensive individuals. Consequently, the present study may not have necessarily detected a positive correlation between LVMI and NHE activity that is confined to individuals with hypertension. Interestingly, although the numbers of normotensives (n ϭ 7; blood pressure Ͻ140/90 mm Hg) and hypertensive (n ϭ 13; blood pressure Ͼ140/90 mm Hg) were small, further analysis showed no significant correlation between LVMI and platelet NHE activity in either of these respective groups when analysed separately. Hence, it appears unlikely that the inclusion of normotensive individuals would account for the difference in the findings of this study. Secondly, it is possible that differences in the methods used to estimate activity of the NHE may account for the discrepancy seen in the findings of the present and aforementioned studies. However, although the methods employed here to measure activity of the NHE may have varied considerably from those used to assess activity in erythrocytes, 16, 24 they were essentially identical to those in the aforementioned study conducted in leucocytes. 15 As such, variations in methodology are unlikely to account for the discrepancy in the results of the present study. Furthermore, the numbers investigated here were comparable to those included in the study conducted in leucocytes by Strazullo et al 15 (n ϭ 18) and could have been expected to show a significant correlation between exchanger activity and LVMI in the presence of a significant relationship between the two parameters. In fact, the coefficient of correlation between exchanger activity and LVMI was calculated to be 0.06 (P ϭ 0.8) and indicates that the relationship between the two parameters, even if detected in a much larger sample, would only be very weak. Thus, the contrast in results between the present and latter studies indicates that the relationship between LVMI and NHE may be specific to the cell type in which exchanger activity is measured and, raises several issues regarding the choice of cell type in assessing the NHE and its contribution to the development of LVH.
It is likely that the regulation and activity of the NHE in platelets may be different from that in leucocytes and other nucleated cells, including cardiomyocytes. Consequently, assessment of exchanger activity in platelets may be limited in resolving the role of exchanger activity in the development of LVH. In this context, several observations regarding the activity of the NHE during metabolic acidosis are perhaps pertinent: first, activity of the NHEeither in association with chronic renal failure in affected patients or through ammonium chloride ingestion in healthy normal volunteers -is associated with an increase in the activity of NHE in lymphocytes but not platelets; 25 and secondly, that such enhancement in NHEa of lymphocytes was found to be associated with increased expression of NHE-1 mRNA, 26 suggesting increased expression of the NHE-1 antiporter during acidosis. Thus, if increased exchanger activity were indeed associated with increased cardiac growth, an enhancement in exchanger activity resulting from greater de novo expression of the exchanger would not necessarily be detected in platelets or other non-nucleated cells. Indeed, it is notable that cardiac growth and proliferation have been found to be accompanied by increased expression of NHE-1 isoform. 27 Hence, although this study does not necessarily exclude a possible relationship between left ventricular mass and NHE, it does indicate that exchanger activity measured in platelets may be limited in delineating the role of the exchanger in the development of LVH.
In conclusion, this study shows that there does not appear to be a significant relationship between platelet NHEa and left ventricular mass or between platelet NHEa and LVMI. As such, this study fails to support the hypothesis that left ventricular mass is related to or may be predicted by maximal rates of NHEa measured in isolated platelets. These data contrast with previously reported associations of left ventricular mass and LVMI with NHE measured in leucocytes and platelets. They suggest that the relationship between exchanger activity and LVMI may be specific to cell type. Although the findings of the present study do not exclude the potential involvement of NHEa in the development of LVH, they do underline the importance of cell type in assessing the role of NHE in the development of LVH.
